The Role of Robusta Green Bean Extract in Decreasing Il-1β Levels on Dental Pulp Stem Cells (Dpsc) Induced by Lps Porphyromonas Gingivalis

Author:

Josefina Savitri Irma1,Tri Medianto Hendi1,Najatus Sakinah Neira1,Putri Priambodo Amelia1,Putri Kalista Vinda1,Hari Padmini2,Maduratna Ernie1

Affiliation:

1. Department of Periodontology, Faculty of Dental Medicine, Universitas Airlangga, Surabaya – Indonesia.

2. Department of Periodontology, Faculty of Dentistry, Mahsa University, Malaysia.

Abstract

Background: Stem cell-based tissue engineering is a potential strategy for periodontal tissue regeneration. Besides the advantages of stem cells as periodontal tissue regenerative therapy, this therapy must also be able to prevent and control the possibility of inflammation that occurs. Robusta green beans contain anti-inflammationsubstances that may decrease excessive inflammation in stem cell therapy. Purpose: To analyze IL-1β levels after giving Robusta green bean extract to DPSC induced by LPS P. gingivalis. Materials and Methods: This study used DPSC from the extraction of premolar teeth of orthodontic patients. The viability test was performed on the LPS P. gingivalis at 0.5; 1; 5; 10µg/ml and robusta green bean extract at 0.0625%; 0.125%; 0.25%; 0.5%to determine non toxic concentration. The treatment group was divided into 4 groups, the control group, the DPSC+LPS group, the DPSC + LPS + 0.125% Robusta green bean extract group, and the DPSC+LPS+0.0625%Robusta green bean extract group.Each group was observed at 24, 48, and 72 hours. ELISA test was performed on the supernatant to measure IL-1β levels. Results: The level of IL-1β in the Robusta green bean extract group was significantly lower (p <0.05) than the group without Robusta green bean extract at all observation times. Conclusion: Robusta green bean extract concentrations of 0.125% and 0.0625% can significantly reduce IL-1β levels in DPSC induced by LPS P. gingivalis, which is the most effective at reducing IL-1β levels was 0.125%.

Publisher

A and V Publications

Subject

Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3